Mentioned In Despatches: Ablynx's Story From The Frontline Of The Biotech Boom

 
• By Jo Shorthouse

A little over 12 months ago, Belgian Nanobody biotech Ablynx was at the center of a bidding war between Novo Nordisk and Sanofi. Ex-Ablynx CEO Edwin Moses talked to Scrip about the four-month period that changed the course of the company.

Microphones
Edwin Moses Tells His Side Of The Ablynx Acquisition • Source: Shutterstock

More from Deals

More from Business